Compensated Cirrhosis
📧 Sign up to get email alerts when something new happens for Compensated Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH [Phase 2]
A Phase 2 study evaluating the tolerability of BI 770371 in people with compensated cirrhosis due to MASH has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) [Phase 2]
ALPINE 4, a Phase 2 study of Aldafermin (NGM282) in subjects with compensated cirrhosis and nonalcoholic steatohepatitis, has completed with…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis [NA]
A clinical trial update evaluating the efficacy and safety of chiglitazar for metabolic dysfunction-associated fatty liver disease (MAFLD) w…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis [Phase 3]
Phase 3 study evaluating obeticholic acid for compensated cirrhosis due to nonalcoholic steatohepatitis has completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis [Phase 1]
Phase 1 trial assessing safety and tolerability of cilofexor in participants with primary sclerosing cholangitis and compensated cirrhosis; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) [Phase 3]
Phase 3 trial evaluating safety and efficacy of selonsertib in adults with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH) …
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV [Phase 4]
Phase 4 trial update on the safety and efficacy of grazoprevir and elbasvir for genotype 1 and genotype 6 hepatitis C, with and without HIV,…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease [Phase 3]
This completed Phase 3 trial tested an all-oral regimen of Ombitasvir/Paritaprevir/ritonavir with Dasabuvir, with or without Ribavirin, in a…
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis [Phase 3]
Phase 3 trial evaluating ABT-493/ABT-530 for efficacy and safety in adults with chronic hepatitis C virus infection (genotypes 1, 2, 4, 5, o…
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis [Phase 3]
Phase 3 trial evaluating Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in adults with genotype 1b chronic hepatitis C and compensated cirr…
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Effects of Weight Loss on Portal Pressure in Patients With Overweight/Obesity and Cirrhosis [Phase 2]
Phase 2 clinical trial evaluating the effect of weight loss on portal pressure in patients with overweight/obesity and compensated cirrhosis…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis [Phase 3]
Phase 3 study evaluating ABT-450/ritonavir/ABT-267 (ombitasvir) and ABT-333 (dasabuvir) with ribavirin in treatment-experienced adults with …
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis [Phase 3]
A Phase 3 trial evaluating screening for hepatocellular carcinoma in patients with compensated cirrhosis has completed.